STRO: Sutro Biopharma, Inc. Company Profile & Statistics

About

Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.

Info & Links

CEO

William J. Newell

Headquarters

111 Oyster Point Blvd.
South San Francisco, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

310

Sutro Biopharma, Inc. Statistics

Valuation Measures

Market Capitalization²

45.15M

Enterprise Value

-145.15M

Enterprise Value/EBITDA(ttm)

0.60

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.94

Price to Book(mrq)

1.35

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-80.89%

Profit Margin(ttm)

-424.03%

Return on Equity(ttm)

-101.89%

Return on Invested Capital(ttm)

-297.23%

Return on Assets(ttm)

-28.69%

Income Statement

Revenue(ttm)

62.04M

Revenue Per Share(ttm)

0.74

Gross Profit(ttm)

62.04M

EBITDA(ttm)³

-240.95M

Net Income Available to Common(ttm)

-227.46M

Diluted EPS(ttm)

-1.61

Share Statistics

Beta (5Y Monthly)

1.15

52-Week Change

-86.00%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

83.78M

Dividend Yield

0.00%

Float⁴

77.59M

% Held by Insiders

5.90%

% Held by Institutions

96.99%

Balance Sheet

Total Cash(mrq)

316.89M

Total Cash Per Share(mrq)

3.78

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.60%

Quick Ratio(mrq)

3.09%

Book Value Per Share(mrq)

0.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.49

Free Cash Flow(ytd)

-194.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

STRO

Sutro Biopharma, Inc.

Sutro Biopharma, Inc. Profile